Back to Journals » Therapeutics and Clinical Risk Management » Volume 11

Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash

Total article views   HTML views PDF downloads Totals
16,219 Dovepress* 15,108+ 1,454 16,562
PubMed Central* 1,111 307 1,418
Totals 16,219 1,761 17,980
*Since 4 September 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 1 0 0 3 4

View citations on PubMed Central and Google Scholar